STOCK TITAN

Ametek Financials

AME
FY2025 annual
Revenue $7.4B +6.6% YoY
Net Income $1.5B +7.6% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow $1.7B -1.8% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Ametek (AME) reported $7.4B in revenue for fiscal year 2025, up 6.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AME FY2025

AMETEK’s engine is acquisition-shaped, low-capital manufacturing that converts revenue into cash while steadily deleveraging the balance sheet.

For two straight years, free cash flow stayed above $1.6B because annual capex was only about $130M, so most operating cash was available for debt reduction, buybacks, or deals. At the same time, goodwill climbed to $7.2B, indicating the asset base has been built more through acquisitions than through heavy internal plant investment.

Margins widened even as SG&A and R&D kept rising, which points to mix improvement or fixed-cost absorption rather than a simple spending freeze. By FY2025, operating margin reached 25.8% and net margin 20.0%, so added sales were arriving with unusually little incremental cost for this scale of revenue.

The company does not carry a big liquidity buffer—cash was only $458M and the current ratio was 1.1x—so this is not a cash-hoard story. Balance-sheet strength has come from steady internal cash generation: long-term debt fell to $1.1B while buybacks and dividends still continued, meaning deleveraging did not require austerity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 70 / 100
Financial Health Score 70/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ametek's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
95

Ametek has an operating margin of 25.8%, meaning the company retains $26 of operating profit per $100 of revenue. This strong profitability earns a score of 95/100, reflecting efficient cost management and pricing power. This is up from 25.6% the prior year.

Growth
54

Ametek's revenue grew 6.6% year-over-year to $7.4B, a solid pace of expansion. This earns a growth score of 54/100.

Leverage
70

Ametek carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 70/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
22

Ametek's current ratio of 1.06 is below the typical benchmark, resulting in a score of 22/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
90

Ametek converts 22.6% of revenue into free cash flow ($1.7B). This strong cash generation earns a score of 90/100.

Returns
86

Ametek earns a strong 13.9% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is down from 14.2% the prior year.

Altman Z-Score Safe
8.09

Ametek scores 8.09, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($55.8B) relative to total liabilities ($5.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Ametek passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.22x

For every $1 of reported earnings, Ametek generates $1.22 in operating cash flow ($1.8B OCF vs $1.5B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
23.51x

Ametek earns $23.51 in operating income for every $1 of interest expense ($1.9B vs $81.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$7.4B
YoY+6.6%
5Y CAGR+10.3%
10Y CAGR+6.4%

Ametek generated $7.4B in revenue in fiscal year 2025. This represents an increase of 6.6% from the prior year.

EBITDA
$2.3B
YoY+7.9%
5Y CAGR+12.7%
10Y CAGR+8.2%

Ametek's EBITDA was $2.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.9% from the prior year.

Net Income
$1.5B
YoY+7.6%
5Y CAGR+11.2%
10Y CAGR+9.6%

Ametek reported $1.5B in net income in fiscal year 2025. This represents an increase of 7.6% from the prior year.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
$1.7B
YoY-1.8%
5Y CAGR+6.7%
10Y CAGR+10.7%

Ametek generated $1.7B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 1.8% from the prior year.

Cash & Debt
$458.0M
YoY+22.4%
5Y CAGR-17.7%
10Y CAGR+1.9%

Ametek held $458.0M in cash against $1.1B in long-term debt as of fiscal year 2025.

Shares Outstanding
229M
YoY-0.7%
5Y CAGR-0.1%
10Y CAGR-0.3%

Ametek had 229M shares outstanding in fiscal year 2025. This represents a decrease of 0.7% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
36.0%
YoY+0.4pp
5Y CAGR+2.0pp
10Y CAGR+1.9pp

Ametek's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the prior year.

Operating Margin
25.8%
YoY+0.2pp
5Y CAGR+3.2pp
10Y CAGR+3.0pp

Ametek's operating margin was 25.8% in fiscal year 2025, reflecting core business profitability. This is up 0.2 percentage points from the prior year.

Net Margin
20.0%
YoY+0.2pp
5Y CAGR+0.8pp
10Y CAGR+5.1pp

Ametek's net profit margin was 20.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.2 percentage points from the prior year.

Return on Equity
13.9%
YoY-0.3pp
5Y CAGR-0.7pp
10Y CAGR-4.2pp

Ametek's ROE was 13.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.3 percentage points from the prior year.

Capital Allocation

R&D Spending
$236.1M
YoY-0.2%
5Y CAGR+8.2%
10Y CAGR+7.3%

Ametek invested $236.1M in research and development in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Share Buybacks
$434.0M
YoY+104.7%
5Y CAGR+147.4%
10Y CAGR0.0%

Ametek spent $434.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 104.7% from the prior year.

Capital Expenditures
$130.2M
YoY+2.5%
5Y CAGR+11.9%
10Y CAGR+6.5%

Ametek invested $130.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2.5% from the prior year.

AME Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AME annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$7.9B$7.4B+6.6%$6.9B+5.2%$6.6B+7.3%$6.2B+10.9%$5.5B+22.2%$4.5B-12.0%$5.2B+6.5%$4.8B+12.7%$4.3B+12.0%$3.8B-3.4%$4.0B-1.2%$4.0B+11.9%$3.6B+7.8%$3.3B+11.5%$3.0B
Cost of Revenue$5.0B$4.7B+6.0%$4.5B+6.0%$4.2B+5.2%$4.0B+10.2%$3.6B+21.3%$3.0B-11.1%$3.4B+5.8%$3.2B+11.4%$2.9B+10.7%$2.6B-1.2%$2.6B-1.6%$2.7BN/AN/AN/A
Gross Profit$2.9B$2.7B+7.7%$2.5B+3.9%$2.4B+11.1%$2.1B+12.2%$1.9B+23.9%$1.5B-13.7%$1.8B+7.7%$1.7B+15.3%$1.4B+14.7%$1.3B-7.5%$1.4B-0.4%$1.4BN/AN/AN/A
R&D ExpensesN/A$236.1M-0.2%$236.6M+7.2%$220.8M+11.1%$198.8M+2.4%$194.2M+22.2%$158.9M-1.9%$161.9M+14.8%$141.0M+8.1%$130.4M+16.4%$112.0M-3.7%$116.3M-2.5%$119.3M+27.1%$93.9M+10.6%$84.9M+8.8%$78.0M
SG&A Expenses$822.2M$757.1M+8.6%$696.9M+2.9%$677.0M+5.0%$644.6M+6.7%$603.9M+17.1%$515.6M-15.5%$610.3M+4.5%$584.0M+9.1%$535.2M+15.4%$463.6M+3.3%$448.6M-3.0%$462.6M+16.2%$398.2M+4.6%$380.5M+8.9%$349.3M
Operating Income$2.0B$1.9B+7.3%$1.8B+4.2%$1.7B+13.8%$1.5B+14.7%$1.3B+27.3%$1.0B-12.7%$1.2B+9.5%$1.1B+19.0%$903.6M+14.2%$791.0M-12.9%$907.7M+1.0%$898.6M+10.2%$815.1M+9.3%$745.9M+17.3%$635.9M
Interest Expense$96.4M$81.3M-28.1%$113.0M+38.1%$81.8M-1.7%$83.2M+3.5%$80.4M-6.6%$86.1M-2.7%$88.5M+7.7%$82.2M-16.2%$98.0M+3.9%$94.3M+2.7%$91.8M+14.8%$79.9M+8.6%$73.6M-2.5%$75.5M+8.2%$69.7M
Income Tax$331.0M$318.2M+11.5%$285.4M-2.7%$293.2M+8.9%$269.1M+15.5%$233.1M+11.1%$209.9M+0.7%$208.5M-0.6%$209.8M+82.0%$115.3M-36.3%$180.9M-16.0%$215.5M-2.2%$220.4M+6.1%$207.8M+2.2%$203.3M+18.1%$172.2M
Net Income$1.6B$1.5B+7.6%$1.4B+4.8%$1.3B+13.3%$1.2B+17.1%$990.1M+13.5%$872.4M+1.3%$861.3M+10.7%$777.9M+14.2%$681.5M+33.1%$512.2M-13.3%$590.9M+1.1%$584.5M+13.0%$517.0M+12.6%$459.1M+19.4%$384.5M

Not reported in any period shown, so not listed: EPS (Diluted).

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

AME Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AME annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$16.1B+9.8%$14.6B-2.6%$15.0B+20.9%$12.4B+4.5%$11.9B+14.9%$10.4B+5.2%$9.8B+13.6%$8.7B+11.1%$7.8B+9.8%$7.1B+6.6%$6.7B+3.7%$6.4B+9.2%$5.9B+13.3%$5.2B+20.2%$4.3B
Current Assets$3.0B+16.0%$2.6B-7.8%$2.8B+11.7%$2.5B+18.8%$2.1B-15.6%$2.5B+24.5%$2.0B+10.3%$1.8B-5.1%$1.9B+0.3%$1.9B+19.1%$1.6B+2.5%$1.6B+15.3%$1.4B+17.5%$1.2B+10.0%$1.1B
Cash & Equivalents$458.0M+22.4%$374.0M-8.7%$409.8M+18.7%$345.4M-0.4%$346.8M-71.4%$1.2B+208.6%$393.0M+11.0%$354.0M-45.2%$646.3M-9.9%$717.3M+88.3%$381.0M+0.9%$377.6M+27.9%$295.2M+86.9%$158.0M-7.3%$170.4M
Inventory$1.1B+8.3%$1.0B-9.8%$1.1B+8.4%$1.0B+35.8%$769.2M+37.6%$559.2M-10.5%$624.6M0.0%$624.7M+15.6%$540.5M+9.8%$492.1M-4.3%$514.5M+3.7%$495.9M+9.5%$452.8M+5.6%$428.9M+12.7%$380.5M
Goodwill$7.2B+9.4%$6.6B+1.7%$6.4B+20.0%$5.4B+2.6%$5.2B+24.0%$4.2B+4.4%$4.0B+12.1%$3.6B+15.9%$3.1B+10.5%$2.8B+4.2%$2.7B+3.5%$2.6B+8.5%$2.4B+9.1%$2.2B+22.3%$1.8B
Total Liabilities$5.4B+9.3%$5.0B-20.9%$6.3B+27.0%$5.0B-1.4%$5.0B+14.0%$4.4B-6.8%$4.7B+7.0%$4.4B+17.3%$3.8B-2.0%$3.8B+12.9%$3.4B+7.1%$3.2B+16.0%$2.7B+3.3%$2.7B+17.1%$2.3B
Current Liabilities$2.8B+35.5%$2.1B-27.2%$2.9B+84.3%$1.6B+0.1%$1.6B+45.3%$1.1B-24.5%$1.4B+13.3%$1.3B+10.5%$1.1B+23.2%$924.4M-9.7%$1.0B+9.4%$936.1M+7.0%$874.5M-0.6%$880.0M+39.9%$628.9M
Long-Term Debt$1.1B-24.6%$1.4B-24.8%$1.9B-12.2%$2.2B-3.2%$2.2B-2.3%$2.3B+0.4%$2.3B-0.1%$2.3B+21.8%$1.9B-9.5%$2.1B+32.8%$1.6B+8.8%$1.4B+25.1%$1.1B+0.8%$1.1B+0.9%$1.1B
Total Equity$10.6B+10.1%$9.7B+10.6%$8.7B+16.8%$7.5B+8.8%$6.9B+15.5%$5.9B+16.3%$5.1B+20.6%$4.2B+5.3%$4.0B+23.7%$3.3B+0.1%$3.3B+0.5%$3.2B+3.3%$3.1B+23.7%$2.5B+23.5%$2.1B
Retained Earnings$12.3B+10.8%$11.1B+11.2%$9.9B+12.2%$8.9B+12.1%$7.9B+11.4%$7.1B+11.1%$6.4B+13.0%$5.7B+13.0%$5.0B+13.6%$4.4B+10.8%$4.0B+14.5%$3.5B+17.0%$3.0B+18.3%$2.5B+19.3%$2.1B

Not reported in any period shown, so not listed: Accounts Receivable.

AME Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AME annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$2.0B$1.8B-1.5%$1.8B+5.4%$1.7B+51.0%$1.1B-1.0%$1.2B-9.4%$1.3B+14.9%$1.1B+20.4%$925.5M+11.1%$833.3M+10.1%$756.8M+12.5%$672.5M-7.4%$726.0M+9.9%$660.7M+7.9%$612.5M+20.4%$508.6M
Capital Expenditures$135.4M$130.2M+2.5%$127.1M-6.7%$136.2M-2.0%$139.0M+25.6%$110.7M+49.2%$74.2M-27.5%$102.3M+24.7%$82.1M+9.3%$75.1M+18.6%$63.3M-8.4%$69.1M-3.1%$71.3M+12.7%$63.3M+10.3%$57.4M+13.0%$50.8M
Free Cash Flow$1.8B$1.7B-1.8%$1.7B+6.4%$1.6B+58.3%$1.0B-3.8%$1.0B-13.0%$1.2B+19.2%$1.0B+20.0%$843.4M+11.2%$758.2M+9.3%$693.6M+14.9%$603.5M-7.8%$654.6M+9.6%$597.3M+7.6%$555.0M+21.3%$457.7M
Investing Cash Flow-$1.4B-$1.1B-334.1%-$244.8M+89.7%-$2.4B-329.9%-$552.8M+73.1%-$2.1B-3435.8%$61.6M+105.4%-$1.2B+4.9%-$1.2B-93.4%-$625.8M-38.3%-$452.4MN/AN/A-$460.3M+42.7%-$803.7M-52.7%-$526.5M
Financing Cash Flow-$685.0M-$686.3M+57.2%-$1.6B-329.8%$697.3M+221.1%-$575.7M-1563.5%$39.3M+107.3%-$539.4M-839.8%$72.9M+459.1%$13.0M+104.0%-$329.2M-676.9%$57.1MN/AN/A-$70.3M-140.3%$174.5M+447.9%$31.9M
Dividends Paid$298.0M$285.3M+10.3%$258.8M+12.4%$230.3M+13.9%$202.2M+9.5%$184.6M+11.9%$165.0M+29.4%$127.5M-1.1%$128.9M+55.8%$82.7M-0.6%$83.3M-3.2%$86.0M+6.7%$80.6M+37.9%$58.4M+10.0%$53.1M+38.4%$38.4M
Share Buybacks$444.0M$434.0M+104.7%$212.0M+2628.1%$7.8M-97.7%$332.8M+2162.4%$14.7M+214.0%$4.7M-60.7%$11.9M-96.8%$367.7M+5254.3%$6.9M-98.0%$336.1M-22.8%$435.4M+77.5%$245.3M+2796.9%$8.5M+82.4%$4.6M-92.2%$59.3M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

AME Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AME annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin36.0%+0.4pp35.7%-0.5pp36.1%+1.3pp34.9%+0.4pp34.5%+0.5pp34.0%-0.6pp34.6%+0.4pp34.3%+0.8pp33.5%+0.8pp32.7%-1.5pp34.1%+0.3pp33.8%N/AN/AN/A
Operating Margin25.8%+0.2pp25.6%-0.2pp25.9%+1.5pp24.4%+0.8pp23.6%+1.0pp22.6%-0.2pp22.8%+0.6pp22.2%+1.2pp21.0%+0.4pp20.6%-2.2pp22.8%+0.5pp22.3%-0.3pp22.7%+0.3pp22.4%+1.1pp21.3%
Net Margin20.0%+0.2pp19.8%-0.1pp19.9%+1.1pp18.9%+1.0pp17.8%-1.4pp19.2%+2.5pp16.7%+0.7pp16.1%+0.2pp15.8%+2.5pp13.3%-1.5pp14.9%+0.3pp14.5%+0.2pp14.4%+0.6pp13.8%+0.9pp12.9%
Return on Equity13.9%-0.3pp14.2%-0.8pp15.0%-0.5pp15.5%+1.1pp14.4%-0.3pp14.7%-2.2pp16.8%-1.5pp18.3%+1.4pp16.9%+1.2pp15.7%-2.4pp18.1%+0.1pp18.0%+1.6pp16.5%-1.6pp18.1%-0.6pp18.7%
Return on Assets9.2%-0.2pp9.4%+0.7pp8.7%-0.6pp9.3%+1.0pp8.3%-0.1pp8.4%-0.3pp8.8%-0.2pp9.0%+0.2pp8.7%+1.5pp7.2%-1.7pp8.9%-0.2pp9.1%+0.3pp8.8%-0.1pp8.8%-0.1pp8.9%
Current Ratio1.06-0.2x1.24+0.3x0.98-0.6x1.62+0.3x1.36-1.0x2.34+0.9x1.420.0x1.46-0.2x1.70-0.4x2.09+0.5x1.58-0.1x1.69+0.1x1.57+0.2x1.32-0.4x1.68
Debt-to-Equity0.100.0x0.15-0.1x0.22-0.1x0.290.0x0.32-0.1x0.38-0.1x0.44-0.1x0.54+0.1x0.46-0.2x0.63+0.2x0.480.0x0.44+0.1x0.36-0.1x0.45-0.1x0.55
FCF Margin22.6%-1.9pp24.5%+0.3pp24.2%+7.8pp16.4%-2.5pp18.9%-7.6pp26.6%+7.0pp19.6%+2.2pp17.4%-0.2pp17.6%-0.4pp18.1%+2.9pp15.2%-1.1pp16.3%-0.3pp16.6%0.0pp16.7%+1.3pp15.3%

Similar Companies

Frequently Asked Questions

What is Ametek's annual revenue?

Ametek (AME) reported $7.4B in total revenue for fiscal year 2025. This represents a 6.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ametek's revenue growing?

Ametek (AME) revenue grew by 6.6% year-over-year, from $6.9B to $7.4B in fiscal year 2025.

Is Ametek profitable?

Yes, Ametek (AME) reported a net income of $1.5B in fiscal year 2025, with a net profit margin of 20.0%.

Ametek (AME) had EBITDA of $2.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Ametek (AME) had $458.0M in cash and equivalents against $1.1B in long-term debt.

Ametek (AME) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ametek (AME) had an operating margin of 25.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ametek (AME) had a net profit margin of 20.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ametek (AME) has a return on equity of 13.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ametek (AME) generated $1.7B in free cash flow during fiscal year 2025. This represents a -1.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ametek (AME) generated $1.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ametek (AME) had $16.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Ametek (AME) invested $130.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ametek (AME) invested $236.1M in research and development during fiscal year 2025.

Yes, Ametek (AME) spent $434.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Ametek (AME) had 229M shares outstanding as of fiscal year 2025.

Ametek (AME) had a current ratio of 1.06 as of fiscal year 2025, which is considered adequate.

Ametek (AME) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ametek (AME) had a return on assets of 9.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Ametek (AME) has an Altman Z-Score of 8.09, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ametek (AME) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ametek (AME) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ametek (AME) has an interest coverage ratio of 23.51x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ametek (AME) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top